Susceptibility of VLDL to oxidation in patients on regular haemodialysis

Atherosclerosis

Volumn 129, Issue 2, 1997, Pages 215-220

  McEneny, Jane ^a   Loughrey, Clodagh M ^a,b   McNamee, Peter T ^b   Trimble, Elisabeth R ^a   Young, Ian S ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

conjugated diene formation; copper induced lipid peroxidation; lipid hydroperoxides; malondialdehyde; susceptibility to oxidation

Indexed keywords

MALONALDEHYDE; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID OXIDATION; LIPID PEROXIDATION; MACROPHAGE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; LIPOPROTEINS, VLDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; RENAL DIALYSIS; VITAMIN E;

EID: 0030896575     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06019-4     Document Type: Article

References (32)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:698.
2. Raine AEG, MacMahon SH, Selwood NH, Wing AJ, Brunner FP. Mortality from myocardial infarction in patients on renal replacement therapy. Nephrol Dial Transplant 1991;6:902.
3. Degoulet P, Legrain M, Reach I, et al. Mortality risk factors in patients treated by chronic haemodialysis. Nephron 1982;31:103.
4. Witztum JL, Steinberg D. Role of oxidised low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785.
5. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee P, Trimble ER. Oxidative stress in haemodialysis. Q J Med 1994;87:679.
6. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of haemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995;41:1135.
7. Nguyen AT, Lethias C, Zingraff J, Herbelin A, Naret C, Descamps-Latscha B. Haemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985;28:158.
8. Peuchant E, Carbonneau M-A, Dubourg L, et al. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. Free Radic Biol Med 1994;16:339.
9. Loughrey CM, Young IS, McEneny J, et al. Oxidation of low density lipoprotein in patients on regular haemodialysis. Atherosclerosis 1994;110:185.
10. Schulz T, Schiffl H, Scheithe R, Hrboticky N, Lorenz R. Preserved antioxidative defense of lipoproteins in renal failure and during dialysis. Am J Kid Dis 1995;25:564.
11. Sutherland WHF, Walker RJ, Ball RJ, Stapley SA, Robertson MC. Oxidation of low density lipoproteins from patients with renal failure or renal-transplants. Kidney Int 1995;48:227.
12. Attman P-O, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kid Dis 1993;21:573.
13. Norbeck HE, Carlson LA. Increased frequency of late pre-β lipoproteins (Lpβ) in isolated serum very low density lipoprteins in uremia. Eur J Clin Invest 1980;10:423.
14. Zacchello G, Pagnan A, Sidran MP et al. Further definition of lipid-lipoprotein abnormalities in children with various degrees of chronic renal insufficiency. Pediatr Res 1987;21:462.
15. Mahley RW, Innerarity TL, Brown MS, Ho YK, Goldstein JL. Cholesterol ester synthesis in macrophages: stimulation by β-very low density lipoproteins from cholesterol-fed rabbits of several species. J Lipid Res 1980;21:970.
16. Parthasarathy S, Quinn MT, Schwenke DC, Carew T, Steinberg D. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis 1989;9:398.
17. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem 1965;2:235.
18. Becker W. Determination of antisera titres using the single radial immunodiffusion method. Immunochem 1969;6:539.
19. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28:504.
20. Wolff SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Method Enzymol 1994;233:182.
21. Naurooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994;220:403.
22. Thurnham DI, Smith E, Flora PS. Concurrent liquid-chromatographic assay of retinol, alpha tocopherol, beta carotene, alpha carotene, lycopene and beta cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 1988;34:377.
23. McDowell IFW, McEneny J, Trimble ER. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 1995;32:167.
24. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH. Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 1993;102:63.
25. Cominacini L, Garbin U, Pastorino AM et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 1993;99:63.
26. Maggi E, Bellazzi R, Falaschi F, et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 1994;45:876.
27. Hahn R, Oette K, Mondorf H, Finke K, Sieberth HG. Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 1983;48:279.
28. Attman P-O, Alaupovic P. Abnormalities of lipoprotein composition in chronic renal insufficiency. Prog Lipid Res 1991;30:275.
29. Horrigan S, Campbell JH, Campbell GR. Oxidation of β-very-low density lipoprotein by endothelial cells enhances its metabolism by smooth muscle cells in culture. Arterioscler Thromb 1991;11:279.
30. Mohr D, Stocker, R. Radical-mediated oxidation of isolated very-low-density lipoprotein. Arterioscler Thromb 1994;14:1186.
31. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341.
32. Bowry VW, Stocker R. Tocopherol-mediated peroxidation: the pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993;115:6029.